Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
---|---|---|---|
Takhzyro | lanadelumab | 2018-11-22 | Takeda Pharmaceuticals International AG Ireland Branch |
EMA:Drugs approved by European Medicines Agency through centralized Procedure.
HMA:Drugs approved by EU members through Mutual Recognition Procedure.
For more information check in official website of members:
Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
---|---|---|---|
Takhzyro | lanadelumab | 2018-11-22 | Takeda Pharmaceuticals International AG Ireland Branch |